BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10796895)

  • 1. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays.
    Ireland JH; O'Donnell B; Basuni AA; Kean JD; Wallace LA; Lau GK; Carman WF
    Hepatology; 2000 May; 31(5):1176-82. PubMed ID: 10796895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
    Sayiner AA; Ozcan A; Sengonul A
    J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.
    Moerman B; Moons V; Sommer H; Schmitt Y; Stetter M
    Clin Lab; 2004; 50(3-4):159-62. PubMed ID: 15074469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic properties of mutant hepatitis B virus surface antigen].
    Guo MZ; Yi Y; Chen SY; Bai Y; Jia ZY; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):48-50. PubMed ID: 18414700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.
    Bauer T; Weinberger K; Jilg W
    Hepatology; 2002 Feb; 35(2):455-65. PubMed ID: 11826423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
    Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
    J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay.
    Echevarría JM; Avellón A
    J Med Virol; 2008 Apr; 80(4):598-602. PubMed ID: 18297712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.
    Weber B
    J Clin Virol; 2005 Feb; 32(2):102-12. PubMed ID: 15653412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
    Weber B; Van der Taelem-Brulé N; Berger A; Simon F; Geudin M; Ritter J
    J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.
    Avellón A; Echevarría JM; Weber B; Weik M; Schobel U; Willems WR; Gerlich WH
    J Med Virol; 2011 Jan; 83(1):95-100. PubMed ID: 21108344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
    Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
    Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
    Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
    Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.
    Servant-Delmas A; Mercier-Darty M; Ly TD; Wind F; Alloui C; Sureau C; Laperche S
    J Clin Virol; 2012 Apr; 53(4):338-45. PubMed ID: 22296790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.
    Jeantet D; Chemin I; Mandrand B; Tran A; Zoulim F; Merle P; Trepo C; Kay A
    J Med Virol; 2004 Aug; 73(4):508-15. PubMed ID: 15221893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg.
    Lu X; Weiss P; Block T
    J Virol Methods; 2004 Jul; 119(1):51-4. PubMed ID: 15109821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.